Enimmune corporation Market Cap

Enimmune corporation has a market cap or net worth of 1.08 billion as of July 15, 2025. Its market cap has decreased by -52.29% in one year.

Market Cap

1.08B

Enterprise Value

801.54M

Revenue

39.92M

Ranking

n/a

PE Ratio

n/a

Stock Price

15.15

Market Cap Chart

Since September 18, 2018, Enimmune corporation's market cap has decreased from 1.33B to 1.08B, a decrease of -18.82%. That is a compound annual growth rate of -3.01%.

Market Cap History

Date	Market Cap	% Change
Jul 15, 2025	1.08B	-39.96%
Dec 31, 2024	1.80B	-27.21%
Dec 29, 2023	2.47B	-38.63%
Dec 30, 2022	4.02B	69.85%
Dec 30, 2021	2.37B	-11.74%
Dec 31, 2020	2.68B	155.47%
Dec 31, 2019	Pro	Pro
Dec 26, 2018	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Caliway Biopharmaceuticals	188.45B
PharmaEssentia	174.63B
Bora Pharmaceuticals Co., LTD.	84.20B
Lotus Pharmaceutical	55.75B
Polaris Group	29.28B
Oneness Biotech	28.93B
Center Laboratories	26.67B
Lumosa Therapeutics	23.21B

Market Cap Rankings